Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	42.18	10.55	7.42
Graham Fair Price	-3.04	21.63	22.31
PEG	433.95	-0.72	0.14
Price/Book	27.42	0.98	0.77
Price/Cash Flow	5111.78	300.05	5.76
Prices/Earnings	44.30	7.23	5.01
Price/Sales	38.93	10.87	7.82
Price/FCF	5111.78	300.05	5.76
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	inf	0.00	1.00
Operating Margin	36267.30	0.54	< 0.005
ROA	60.71	0.09	0.06
ROE	0.04	0.03	-11.70
ROIC	< 0.005	-0.02	-19101.70
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.29	-0.05	510.33
Dividends QOQ	< 0.005	0.02	2448.89
EBIT QOQ	0.00	340.47	100.00
EPS QOQ	0.37	-0.10	-72.98
FCF QOQ	5.45	-0.97	-82.11
Revenue QOQ	0.17	-0.06	-64.70
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	126.24	131.57	4.22
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.34	0.40	15.80
Quick Ratio	1.78	3.30	85.32
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	23.98	24.75	3.18
Cash	23.78	29.86	25.55
Capex	< 0.005	< 0.005	77.85
Free Cash Flow	3.21	0.08	-97.48
Revenue	2.36	2.24	-5.37
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.69	0.27	-60.26
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.22	-7.74	-48.20
Naive Interpretation	Member

06 - Financial Health · Bad

Rating